Labiotech.eu (blog)Is DNA the Future? The Best Biotech Talks of the YearLabiotech.eu (blog)Drew Endy is considered one of the fathers of the field of synthetic biology. In his keynote at SynBioBeta in London this year, he gave an overview of how the fi… Continue reading
South China Morning PostGene therapy helps late-stage leukaemia patients for whom other treatments failedSouth China Morning PostGene therapy helps late-stage leukaemia patients for whom other treatments failed. Leukaemia sufferers in Hong Kong, where … Continue reading
|
CAR T-Cell Therapy for Leukemia Leads to Remissions in Clinical Trial
Newswise (press release) “It was not known whether CAR T-cells could be used to treat these high risk CLL patients,” said lead author Dr. Cameron Turtle, an immunotherapy researcher at Fred Hutch. “Our study shows that CD19 CAR T-cells are a highly promising treatment for CLL … |
The Straits Times |
CAR T-Cell Therapy for Leukemia Leads to Remissions in Clinical Trial
Newswise (press release) “It was not known whether CAR T-cells could be used to treat these high risk CLL patients,” said lead author Dr. Cameron Turtle, an immunotherapy researcher at Fred Hutch. “Our study shows that CD19 CAR T-cells are a highly promising treatment for CLL … Promising immunotherapy helps adults with leukemiaDaily Mail |
Inquirer.net |
Promising immunotherapy helps adults with leukemia
Inquirer.net MIAMI—A cancer treatment that genetically alters immune cells has shown success in 71 percent of adults with the most common form of leukemia, and for whom other medicines had failed, US researchers said Monday. The treatment, known as experimental … |
|
Global Market Study on Allergic Rhinitis Treatment: Immunotherapy Treatment Segment Projected to be the Fastest …
PR Newswire (press release) LONDON, July 17, 2017 /PRNewswire/ — Persistence Market Research in its recent report “Allergic Rhinitis Treatment Market: 2016–2024,” examines the global allergic rhinitis treatment market for the period of eight years. i.e. 2016-2024. The primary … |